Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Dr. Jennifer Garrison, PhD (http://garrisonlab.com/) is Assistant Professor, Buck Institute for Research on Aging, Founder & Faculty Director, Global Consortium for Reproductive Longevity & Equality (https://www.buckinstitute.org/gcrle/), Assistant Professor in Residence, Cellular and Molecular Pharmacology, UCSF and Adjunct Assistant Professor of Gerontology, USC Leonard Davis School of Gerontology.

Dr. Garrison’s lab is interested in understanding how neuropeptides (a large class of signaling molecules which are secreted from neurons and transmit messages within the brain and across the nervous system) regulate changes in normal and aging animals as well in understanding how they control behavior at both the cell biological and neural circuit level.

Dr. Garrison received her PhD from the University of California San Francisco in Chemistry and Chemical Biology in the laboratory of Dr. Jack Taunton, where she discovered the molecular target of a natural product and elucidated a novel mechanism by which small molecules can regulate protein biogenesis. As a postdoctoral fellow in Dr. Cori Bargmann’s lab at the Rockefeller University, she showed that the nematode C. elegans produces a neuropeptide that is an evolutionary precursor of the mammalian peptides vasopressin and oxytocin, and mapped a neural circuit by which this molecule, nematocin, modulates mating behavior.

Dr. Garrison was named an Alfred P. Sloan Research Fellow and received a Glenn Foundation Award for Research in Biological Mechanisms of Aging in 2,014 and a Next Generation Leader at the Allen Institute for Brain Science in 2015. Her work is funded by the NIH National Institute of General Medical Sciences, the Glenn Foundation for Medical Research, the Alfred P. Sloan Foundation, and the Larry L. Hillblom Foundation.

Continue reading “Dr Jennifer Garrison, PhD — Global Consortium for Reproductive Longevity & Equality — Buck Institute” | >

We interviewed four longevity experts (including several Lifeboat Foundation board members) to learn how they think about their diets. I was particularly struck by how different they all were (except almost all of them fasted)!

Food.

In all our research into longevity so far, from quantifying how we sleep to exploring the science behind whether human life extension is possible, nutrition has remained the most controversial and confusing subject that we’ve covered. For example, when we surveyed 101 of our readers on their longevity diet, we got 101 very different answers. There is little consensus on what the perfect life extension diet should look like.

Read more | >

A Chinese Kuaizhou 1A (KZ-1A) rocket lifted off from the Jiuquan Satellite Launch Center in Inner Mongolia at 06:19 UTC on September 27 lofting a new high-resolution remote sensing satellite into orbit.

The rocket lifted off from Site 95 at Jiuquan, marking the 14th flight of a KZ-1 series rocket. This was also the first KZ-1 launch since the Jilin-1 Gaofen-02C launch in September 2,020 which ended in failure and the loss of its payload.

China’s KZ-1A rocket is manufactured by the ExPace Technology Corporation, an aerospace company owned by the Chinese government, based out of Wuhan in China’s Hubei province. The rocket is capable of delivering payloads of up to 200 kg into a Sun-Synchronous Orbit, and therefore is mainly marketed as a small satellite launch vehicle.

Read more | >

Cloudflare, The internet infrastructure company, already has its fingers in a lot of customer security pots, from DDoS protection to browser isolation to a mobile VPN. Now the company is taking on a classic web foe: email.

On Monday, Cloudflare is announcing a pair of email safety and security offerings that it views as a first step toward catching more targeted phishing attacks, reducing the effectiveness of address spoofing, and mitigating the fallout if a user does click a malicious link. The features, which the company will offer for free, are mainly geared toward small business and corporate customers. And they’re made for use on top of any email hosting a customer already has, whether it’s provided by Google’s Gmail, Microsoft 365 Yahoo, or even relics like AOL.

Cloudflare CEO Matthew Prince says that from its founding in 2,009 the company very intentionally avoided going anywhere near the thorny problem of email. But he adds that email security issues are unrelenting, so it has become necessary. “I think what I had assumed is that hosting providers like Google and Microsoft and Yahoo were going to solve this issue, so we weren’t sure there was anything for us to do in the space,” Prince says. “But what’s become clear over the course of the last two years is that email security is still not a solved issue.”

Read more | >

Epic has developed technology that serves as a digital vaccination verification by binding a person’s identity with their vaccination or lab results and displaying it via QR codes on a smartphone, Wisconsin State Journal reported Sept. 27.

Epic has rolled out technology that serves as a digital vaccination verification by binding a person’s identity with their vaccination or lab results and displaying it via QR codes on a smartphone, Wisconsin State Journal reported Sept. 27.

Seven things to know:

1. The new tech is currently live for 25 million patients, and 70 million to 80 million people will have access to it by the end of 2,022 Nick Frenzer, an Epic implementation executive, told the publication.

Continue reading “Epic deploys tech to verify COVID-19 vaccination status, test results” | >

This year’s deadline for applications is November 15 2021. To learn more, visit https://aws.amazon.com/health/health-equity.

AWS is announcing a new global program to support organizations working to enhance health outcomes for underserved or underrepresented communities. We are providing AWS credits and technical expertise, committing $40 million over three years to help organizations develop solutions to improve health outcomes.

Read more | >